This biomedical company develops and manufactures medical devices using AI, 3D printing, and biomaterial processing. They specialize in tissue engineering and regenerative medicine applications, providing environmentally friendly biomaterials and nanomaterials for medical use.
Funding
Funding not disclosed
Founders
Product
Problem
Conventional materials used in medical devices and implants can sometimes lack biocompatibility, hindering osseointegration and potentially leading to implant failure or rejection. Surface treatments using non-resorbable materials may also leave residual particles, causing inflammation and compromising long-term implant stability.
Solution
Medoja Bio provides sustainable biomaterials and nanobiomaterials designed for tissue engineering and regenerative medicine. The company offers a range of products, including nano-hydroxyapatite for toothpaste, hydroxyapatite thermal spray powder for coating orthopedic and dental implants, and resorbable blast media (RBM) for surface treatment of implants. Medoja's resorbable blast media utilizes biocompatible particles to create a clean, roughened implant surface that promotes osseointegration without leaving harmful residues. Their hydroxyapatite thermal spray powder enhances bone cell adhesion and proliferation, improving implant stability and longevity.
Target Audience
Medoja Bio serves dental manufacturers, orthopedic implant companies, and research institutions seeking biocompatible and sustainable biomaterials for medical device applications.
Features
- Nano-hydroxyapatite powder for toothpaste with customizable particle sizes (30-100nm) and high purity (99.5%) for remineralization and caries prevention.
- Hydroxyapatite thermal spray powder for orthopedic and dental implants, enhancing osseointegration and bone regeneration.
- Resorbable Blast Media (RBM) for surface treatment of implants, ensuring minimal residual particles and optimal osteoblast proliferation.
- Beta-tricalcium phosphate (β-TCP) for dental research and regenerative applications.
- MedoSirā bone graft material featuring Calcium-Deficient Apatite (CDA) co-doped with elemental ions for enhanced angiogenic properties.
- Development of Hydroxyapatite for nutraceutical and chromatography applications.
- Magnesium implants for bone regeneration.